


The Vasileva Lab
Hijacked Development in Pediatric Cancers
Center for Cancer and Immunology Research
Children's National Hospital
Washington, DC
Cancer origin
Understanding how oncogenic fusions rewire cell identity and alter developmental trajectories.
Tumor initiation
Leveraging zebrafish genetic models of pediatric cancer to study tumor initiation and establishment in a complex developmental landscape.
Cancer-niche
communication
Defining the role of proteoglycans in orchestrating tumor–microenvironment interactions in pediatric cancer.
Developmental vulnerabilities
Identifying lineage-specific vulnerabilities of cancer cells to advance targeted therapeutic approaches.


Our lab in the Center for Cancer and Immunology Research (CCIR) with the support of the Brain Tumor Institute (BTI) at Children's National Hospital explores the developmental origins of childhood cancer, focusing on the molecular and cellular mechanisms that drive tumor initiation and progression. We develop and utilize genetic zebrafish models of pediatric cancer (New Approach Methodolog, NAM) to investigate how healthy cells are transformed into cancer cells in vivo, how tumor cells hijack developmental signaling pathways for cell transformation and tumor establishment. Ultimately, we aim to leverage these insights to inform preventive strategies and develop new therapeutic approaches.

Zebrafish Development
We are also actively recruiting motivated scientists at multiple levels, including postdoctoral fellows and research technicians. If you are passionate about pediatric cancer research, developmental biology, zebrafish models, or translational science, we would love to hear from you!
Our team in the Center for Cancer and Immunology Research
at Children's National Hospital


Our latest research papers and findings.
Luck et al., 2026
Vasileva et al., 2025
Vasileva et al., 2022
We'd love to hear from you regarding our research or collaborations.







